BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 26708020)

  • 41. Gamma scintigraphy of a 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate containing galactosamine following intravenous administration to nude mice bearing hepatic human colon carcinoma.
    Pimm MV; Perkins AC; Strohalm J; Ulbrich K; Duncan R
    J Drug Target; 1996; 3(5):385-90. PubMed ID: 8866657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and Microenvironment.
    Noack AK; Lucas H; Chytil P; Etrych T; Mäder K; Mueller T
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Highly effective anti-tumor nanomedicines based on HPMA copolymer conjugates with pirarubicin prepared by controlled RAFT polymerization.
    Randárová E; Nakamura H; Islam R; Studenovský M; Mamoru H; Fang J; Chytil P; Etrych T
    Acta Biomater; 2020 Apr; 106():256-266. PubMed ID: 32058082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HPMA copolymer-bound doxorubicin induces immunogenic tumor cell death.
    Sirova M; Kabesova M; Kovar L; Etrych T; Strohalm J; Ulbrich K; Rihova B
    Curr Med Chem; 2013; 20(38):4815-26. PubMed ID: 24083609
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancing Accumulation and Penetration of HPMA Copolymer-Doxorubicin Conjugates in 2D and 3D Prostate Cancer Cells via iRGD Conjugation with an MMP-2 Cleavable Spacer.
    Peng ZH; Kopeček J
    J Am Chem Soc; 2015 Jun; 137(21):6726-9. PubMed ID: 25963409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy: In vitro and in vivo evaluation and direct comparison to poly[N-(2-hydroxypropyl)methacrylamide] analogues.
    Sedlacek O; Monnery BD; Mattova J; Kucka J; Panek J; Janouskova O; Hocherl A; Verbraeken B; Vergaelen M; Zadinova M; Hoogenboom R; Hruby M
    Biomaterials; 2017 Nov; 146():1-12. PubMed ID: 28892751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synergistic enhancement of anticancer therapeutic efficacy of HPMA copolymer doxorubicin conjugates via combination of ligand modification and stimuli-response srategies.
    Li L; Zhou M; Huang Y
    Int J Pharm; 2018 Jan; 536(1):450-458. PubMed ID: 29237570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PDEPT: polymer-directed enzyme prodrug therapy. I. HPMA copolymer-cathepsin B and PK1 as a model combination.
    Satchi R; Connors TA; Duncan R
    Br J Cancer; 2001 Sep; 85(7):1070-6. PubMed ID: 11592781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of primary and metastatic tumors in mice by E-selectin-targeted polymer-drug conjugates.
    Shamay Y; Raviv L; Golan M; Voronov E; Apte RN; David A
    J Control Release; 2015 Nov; 217():102-12. PubMed ID: 26297207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effective doxorubicin-based nano-therapeutics for simultaneous malignant lymphoma treatment and lymphoma growth imaging.
    Etrych T; Daumová L; Pokorná E; Tušková D; Lidický O; Kolářová V; Pankrác J; Šefc L; Chytil P; Klener P
    J Control Release; 2018 Nov; 289():44-55. PubMed ID: 30248447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Self-association properties of HPMA copolymers containing an amphipathic heptapeptide.
    Ding H; Kopecková P; Kopecek J
    J Drug Target; 2007; 15(7-8):465-74. PubMed ID: 17671893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
    Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
    J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
    [TBL] [Abstract][Full Text] [Related]  

  • 53. N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation.
    Searle F; Gac-Breton S; Keane R; Dimitrijevic S; Brocchini S; Sausville EA; Duncan R
    Bioconjug Chem; 2001; 12(5):711-8. PubMed ID: 11562189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improvement of anti-tumor abilities on human non-small cell lung carcinoma by micellization and cross-linking of N-(2-hydroxypropyl) methacrylamide copolymers.
    Zhou Z; Xu X; Li L; Huang Y
    J Drug Target; 2015; 23(9):821-31. PubMed ID: 25830626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.
    Duncan R; Kopecková P; Strohalm J; Hume IC; Lloyd JB; Kopecek J
    Br J Cancer; 1988 Feb; 57(2):147-56. PubMed ID: 3358905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis of poly[N-(2-hydroxypropyl)methacrylamide] conjugates of inhibitors of the ABC transporter that overcome multidrug resistance in doxorubicin-resistant P388 cells in vitro.
    Subr V; Sivák L; Koziolová E; Braunová A; Pechar M; Strohalm J; Kabešová M; Ríhová B; Ulbrich K; Kovář M
    Biomacromolecules; 2014 Aug; 15(8):3030-43. PubMed ID: 24978588
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells.
    Malugin A; Kopecková P; Kopecek J
    J Control Release; 2007 Dec; 124(1-2):6-10. PubMed ID: 17869367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polymeric drugs based on conjugates of synthetic and natural macromolecules. II. Anti-cancer activity of antibody or (Fab')(2)-targeted conjugates and combined therapy with immunomodulators.
    Ríhová B; Jelínková M; Strohalm J; Subr V; Plocová D; Hovorka O; Novák M; Plundrová D; Germano Y; Ulbrich K
    J Control Release; 2000 Feb; 64(1-3):241-61. PubMed ID: 10640661
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Indium-based and iodine-based labeling of HPMA copolymer-epirubicin conjugates: Impact of structure on the in vivo fate.
    Zhang L; Zhang R; Yang J; Wang J; Kopeček J
    J Control Release; 2016 Aug; 235():306-318. PubMed ID: 27266365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity.
    Ulbrich K; Etrych T; Chytil P; Jelínková M; Ríhová B
    J Control Release; 2003 Feb; 87(1-3):33-47. PubMed ID: 12618021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.